HER2 amplification status was further compared between HER2 NGS and FISH testing to determine whether HER2 amplification status by NGS could be useful to reveal a subset of HER2-positive breast carcinomas with a negative IHC and a positive HER2 FISH result. Here, ERBB2 is linked to breast carcinoma.